| Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors (NCT04096638) | invoX Pharma Limited | 2019-09-23 |
| The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% (NCT04212429) | National University of Malaysia | 2019-09-23 |
| Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) (NCT04093596) | Allogene Therapeutics | 2019-09-23 |
| Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin (NCT03985969) | Genfit | 2019-09-23 |
| The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% (NCT04214821) | National University of Malaysia | 2019-09-23 |
| Trial of C134 in Patients With Recurrent GBM (NCT03657576) | University of Alabama at Birmingham | 2019-09-23 |
| CG-549 Tablet Pharmacokinetics Study (NCT05393856) | CrystalGenomics, Inc. | 2019-09-23 |
| Deflox Tablets Bioequivalence (BE) Trial (NCT04132583) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2019-09-21 |
| Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib (NCT04079738) | H Scott Boswell | 2019-09-20 |
| Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox (NCT04030767) | Cairo University | 2019-09-20 |
| Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy (NCT03847467) | Children's Hospital Medical Center, Cincinnati | 2019-09-20 |
| Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NCT03991819) | University Health Network, Toronto | 2019-09-20 |
| A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors (NCT04047290) | Akesobio Australia Pty Ltd | 2019-09-20 |
| Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects (NCT04112446) | Zydus Therapeutics Inc. | 2019-09-20 |
| A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718 (NCT04087187) | AstraZeneca | 2019-09-20 |
| A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects. (NCT04072562) | AstraZeneca | 2019-09-19 |
| Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function (NCT02359825) | Vanderbilt University Medical Center | 2019-09-19 |
| Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects (NCT04155814) | Baxter Healthcare Corporation | 2019-09-19 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect (NCT04077879) | Astellas Pharma Global Development, Inc. | 2019-09-19 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers (NCT04075643) | Chong Kun Dang Pharmaceutical | 2019-09-19 |
| A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS) (NCT04079296) | Astellas Pharma Global Development, Inc. | 2019-09-19 |
| Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (NCT04169191) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2019-09-19 |
| Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer (NCT03942328) | Mayo Clinic | 2019-09-19 |
| Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (NCT04471818) | Instituto Nacional de Cancerologia de Mexico | 2019-09-19 |
| Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects (NCT04019444) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-09-19 |
| A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667 (NCT04097938) | Lakefront Biotherapeutics NV | 2019-09-18 |
| Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation (NCT04098393) | Memorial Sloan Kettering Cancer Center | 2019-09-18 |
| A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors (NCT03934359) | Shanghai De Novo Pharmatech Co., Ltd. | 2019-09-18 |
| Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer (NCT02595879) | National Cancer Institute (NCI) | 2019-09-18 |
| A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas (NCT04104776) | Novartis Pharmaceuticals | 2019-09-18 |
| Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease (NCT04088734) | Ultragenyx Pharmaceutical Inc | 2019-09-18 |
| Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects (NCT04479891) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-18 |
| Ixazomib + Pomalidomide + Dexamethasone In MM (NCT04094961) | Omar Nadeem, MD | 2019-09-18 |
| Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury (NCT03945110) | The University of Western Australia | 2019-09-18 |
| Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers (NCT04097405) | InventisBio Co., Ltd | 2019-09-18 |
| Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks (NCT03905408) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-09-17 |
| GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors (NCT04083599) | Genmab | 2019-09-17 |
| A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects (NCT04104503) | H. Lundbeck A/S | 2019-09-17 |
| PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin (NCT04021277) | EXACT Therapeutics AS | 2019-09-17 |
| Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso (NCT03950739) | United Therapeutics | 2019-09-17 |
| The Pharmacokinetics of GLA5PR Tablet According to the Renal Function (NCT03963362) | GL Pharm Tech Corporation | 2019-09-17 |
| Safety Study of SLC-391 in Subjects With Solid Tumors (NCT03990454) | SignalChem Lifesciences Corporation | 2019-09-17 |
| Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects (NCT04138836) | Bridge Biotherapeutics, Inc. | 2019-09-17 |
| Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers (NCT04246749) | Crinetics Pharmaceuticals Inc. | 2019-09-17 |
| A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma (NCT04095221) | Memorial Sloan Kettering Cancer Center | 2019-09-17 |
| A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients (NCT04041011) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-17 |
| A Phase I Study of TACI-antibody Fusion Protein Injection (RC18) in Healthy Adult Chinese Subjects (NCT04235933) | RemeGen Co., Ltd. | 2019-09-17 |
| Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects (NCT04097288) | University Hospital Bispebjerg and Frederiksberg | 2019-09-17 |
| The Trauma INtramuscular Tranexamic Acid Clinical Trial (NCT03875937) | London School of Hygiene and Tropical Medicine | 2019-09-17 |
| Safety and Tolerability of PNT001 in Healthy Adults (NCT04096287) | Pinteon Therapeutics, Inc | 2019-09-17 |
| Pharmacokinetics in End Stage Renal Disease Patients (NCT04792333) | Quantum Genomics SA | 2019-09-17 |
| Cortiment® MMX Pharmacokinetic Study (NCT04080713) | Ferring Pharmaceuticals | 2019-09-16 |
| Multiple Ascending Oral Dose 14-Day Trial of LHF-535 in Healthy Participants (NCT03993704) | Kineta Inc. | 2019-09-16 |
| The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth (NCT03992534) | Imperial College London | 2019-09-16 |
| A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants (NCT04090086) | Janssen Research & Development, LLC | 2019-09-16 |
| Cannabidiol as a Treatment for AUD Comorbid With PTSD (NCT03248167) | NYU Langone Health | 2019-09-16 |
| A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma (NCT03802071) | Yonsei University | 2019-09-16 |
| A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants (NCT04087759) | Janssen Research & Development, LLC | 2019-09-16 |
| Single Ascending Dose Study of ALA-1000 (NCT04122755) | Alar Pharmaceuticals Inc. | 2019-09-16 |
| Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. (NCT03887169) | Assistance Publique - Hôpitaux de Paris | 2019-09-16 |
| QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma (NCT04052061) | ImmunityBio, Inc. | 2019-09-16 |
| Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer (NCT04138342) | Al-Azhar University | 2019-09-15 |
| Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma (NCT03871959) | Centre Leon Berard | 2019-09-15 |
| Insulin Tolerance Test Study in Patients With Type 1 Diabetes (NCT04026750) | High Point Clinical Trials Center | 2019-09-15 |
| Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT04056975) | EVIVE Biotechnology | 2019-09-15 |
| Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells (NCT04082910) | Chinese PLA General Hospital | 2019-09-15 |
| Anesthetist Controlled Versus Patient-controlled Sedation: Risks and Benefits (NCT04823390) | Cairo University | 2019-09-14 |
| A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection (NCT04136327) | Lakefront Biotherapeutics NV | 2019-09-13 |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334 (NCT04086602) | Inflazome UK Ltd | 2019-09-13 |
| Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer (NCT04013542) | M.D. Anderson Cancer Center | 2019-09-13 |
| The Use of Trifluoperazine in Transfusion Dependent DBA (NCT03966053) | Adrianna Vlachos, MD | 2019-09-13 |
| COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC (NCT04068610) | MedImmune LLC | 2019-09-13 |
| Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant (NCT03259503) | M.D. Anderson Cancer Center | 2019-09-13 |
| A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes (NCT04050670) | Eli Lilly and Company | 2019-09-13 |
| Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC (NCT04060394) | Laekna Limited | 2019-09-13 |
| Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3 (NCT04098497) | University of Wisconsin, Madison | 2019-09-13 |
| Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant (NCT04074174) | Novo Nordisk A/S | 2019-09-12 |
| Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease (NCT04031729) | Massachusetts General Hospital | 2019-09-12 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ir-CPI in Healthy Male Subjects (NCT04653766) | Bioxodes S.A. | 2019-09-12 |
| A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma (NCT04322292) | Institute of Hematology & Blood Diseases Hospital, China | 2019-09-12 |
| Neuroimmune Effects of Opioid Administration (NCT03801629) | Yale University | 2019-09-12 |
| Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) (NCT05084391) | M.D. Anderson Cancer Center | 2019-09-12 |
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia (NCT04067336) | Kura Oncology, Inc. | 2019-09-12 |
| Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects (NCT04514237) | Boston Pharmaceuticals | 2019-09-12 |
| An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition. (NCT04086719) | Bristol-Myers Squibb | 2019-09-12 |
| Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies (NCT04088890) | Matthew Frank | 2019-09-12 |
| Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects (NCT04079062) | Ono Pharmaceutical Co., Ltd. | 2019-09-12 |
| HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388) | M.D. Anderson Cancer Center | 2019-09-12 |
| Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients (NCT04121455) | TME Pharma AG | 2019-09-12 |
| Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) (NCT04046887) | Patrick Joseph Loehrer Sr. | 2019-09-11 |
| Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord (NCT03562065) | Assistance Publique - Hôpitaux de Paris | 2019-09-11 |
| Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC (NCT04081688) | Rutgers, The State University of New Jersey | 2019-09-11 |
| Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS) (NCT03057990) | Montefiore Medical Center | 2019-09-11 |
| A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis (NCT04047771) | Sichuan Clover Biopharmaceuticals, Inc. | 2019-09-10 |
| A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 (NCT04106297) | Lakefront Biotherapeutics NV | 2019-09-10 |
| 6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers (NCT04085224) | LG Chem | 2019-09-10 |
| Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8) (NCT04105010) | Dizal Pharmaceuticals | 2019-09-10 |
| A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors (NCT04172506) | Akeso | 2019-09-10 |
| Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC (NCT03970746) | PDC*line Pharma SAS | 2019-09-10 |
| Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects (NCT04092725) | Scynexis, Inc. | 2019-09-09 |